It is unclear in the U.S. if Cost Effectiveness Research (CER) studies are compelling enough to overturn insurer's coverage decisions or reduce well-established procedures--Beware the status quo
- This article is posted in:
3 poignant cases of overuse, i.e., where over-supply (of docs) leads to over-testing or over-treating .... Goodwin JS, Singh A, Reddy N, Riall TS, Kuo Y-K. [Archives of Internal Medicine; JAMANetwork.com] target="_blank">Overuse of Screening Colonoscopy in the Medicare Population." Arch Intern Med Published online May 9, 2011. doi:10.1001/archinternmed.2011.212
Increasingly, the cost of care is unnecessarily dear, rising exponentially while the return on investment is falling precipitously. What can be done about improving the value of health care?
The number of U.S. total knee arthroplasty (TKA) procedures, an effective, established operation, is huge and it is more cost-effective to do TKA in patients with end-stage osteoarthritis than to treat the patient medically, regardless of the hospital TKA volume. Nevertheless, the larger volume hospitals enjoy the better C:E in part because they have lower cost ratios. There were approximately 500,000 TKAs in 2006 For which the direct medical costs were $11 billion